Two Sigma Investments, LP E Ffector Therapeutics, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.35 - $1.39 $28,545 - $113,365	81,558 New	81,558 $67,000
Q4 2022 Feb 14, 2023	SELL	$0.38 - $0.66 $3,285 - $5,706	-8,646 Reduced 18.31%	38,577 $16,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $1.41 $3,777 - $66,584	47,223 New	47,223 $27,000
Q1 2022 May 16, 2022	SELL	$3.85 - $8.2 $54,369 - $115,800	-14,122 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.71 - $13.15 $80,636 - $185,704	14,122 New	14,122 $117,000

6.53M

Ticker EFTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,452,800
Description
eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.